Circulating serum miR-92a was found to be elevated in patients with sepsis-induced ARDS, and miR-92a inhibitors inhibited LPS-induced apoptosis and inflammatory responses via the Akt/mTOR pathway [69]. This evidence concerns the gene MTOR and Sepsis.